94
Views
3
CrossRef citations to date
0
Altmetric
Article

A review of discrete event simulation in National Coordinating Centre for Health Technology Assessment-funded work and a case study exploring the cost-effectiveness of testing for thrombophilia in patients presenting with an initial idiopathic venous thromboembolism

, , &
Pages 14-23 | Received 15 Oct 2008, Accepted 03 Jun 2009, Published online: 19 Dec 2017

References

  • http://www.cdc.gov/genomics/gtesting/file/print/FBR/VTE_Analval.pdf, accessed 15 March 2007.
  • BartonPThe use of modelling to evaluate new drugs for patients with a chronic condition: The case of antibodies against tumour necrosis factor in rheumatoid arthritisHealth Technol Assess20048110410.3310/hta8110
  • BerryEIntravascular ultrasoundguided interventions in coronary artery disease: A systematic literature review, with decision-analytic modelling, of outcomes and cost-effectivenessHealth Technol Assess20004351117
  • BoccalonHClinical outcome and cost of hospital versus home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: The vascular midi-pyrenees studyArch Intern Med20001601769177310.1001/archinte.160.12.1769
  • British Medical Association and Royal Pharmaceutical Society of Great Britain (2006). British National Formulary (BNF) No. 52, London.
  • CarltonJThe clinical and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: A systematic review and economic evaluationHealth Techol Assess200812251214
  • CastelnuovoEThe effectiveness and cost effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: Systematic review and economic evaluationHealth Technol Assess2005943126210.3310/hta9430
  • ChristiansenSCCannegieterSCKosterTVandenbrouckeJPThrombophilia, clinical factors, and recurrent venous thrombotic eventsJ Amer Med Assoc20052932352236110.1001/jama.293.19.2352
  • ClaxtonKSculpherMMcCabeCProbabilistic sensitivity analyses for NICE technology assessment: Not an optional extraHealth Econ20051433934710.1002/hec.985
  • ColquittJLClinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetesHealth Technol Assess2004843118610.3310/hta8430
  • CurtisLNettenAUnit Costs of Health and Social Care 20062006
  • De StefanoVMartinelliIMannucciPMPaciaroniKThe risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutationN Engl J Med199934180180610.1056/NEJM199909093411104
  • Department of Health (2006). NHS Reference costs 2005–06. London: Department of Health.
  • DickeyTLCan thrombophilia testing help to prevent recurrent VTE? Part 2J Am Acad Phys Assist2002152329
  • DouketisJDKearonCBatesSDukuEkRisk of fatal pulmonary embolism in patients with treated venous thromboembolismJ Amer Med Assoc199827945846210.1001/jama.279.6.458
  • DrummondMFSculpherMJTorranceGWO’BrienBJMethods for the Economic Evaluation of Health Care Programme2005
  • FenwickEClaxtonKSculpherMRepresenting uncertainty: The role of cost-effectiveness acceptability curvesHealth Econ20011077978710.1002/hec.635
  • Fox M et al (2007). The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: Systematic review and economic model. Health Technol Assess 11 (47).
  • FrancoRFReitsmaPHGenetic risk factors of venous thrombosisHum Genet200110936938410.1007/s004390100593
  • GageBFCardinalliABOwensDKThe effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of lifeArch Intern Med19961561829183610.1001/archinte.1996.00440150083009
  • GarsideRThe effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: A systematic review and economic evaluationHealth Technol Assess2005929124610.3310/hta9290
  • GoodacreSSampsonFStevensonMWailooAMeasurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosisHealth Technol Assess200610iii9910.3310/hta10150
  • GoodacreSHow should we diagnose suspected deep vein thrombosis?Q J Med20069937738810.1093/qjmed/hcl051
  • HoWKHankeyGJQuinlanDJEikelboomJWRisk of recurrent venous thromboembolism in patients with common thrombophilia: A systematic reviewArch Intern Med200616672973610.1001/archinte.166.7.729
  • HobbsFDRA randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over The SAFE studyHealth Technol Assess200594019010.3310/hta9400
  • KarnonJA review critique of modelling in prioritising designing screening programmesHealth Technol Assess20071152116610.3310/hta11520
  • KearonCGentMHirshJWeitzJA comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolismN Engl J Med199934090190710.1056/NEJM199903253401201
  • KindPDolanPGudexCWilliamsAVariations in population health status: Results from a United Kingdom national questionnaire surveyBrit Med J199831673674110.1136/bmj.316.7133.736
  • LegnaniCCosmiBCiniMFrascaroMHigh plasma levels of factor VIII and risk of recurrence of venous thromboembolismBrit J Haematol200412450451010.1046/j.1365-2141.2003.04795.x
  • LindmarkerPSchulmanSSten-LinderMWimanBThe risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin geneThromb Haemostasis199981684689
  • LinkinsLAChoiPTDouketisJDClinical impact of bleeding in patients taking oral anticoagulant therapy in venous thromboembolismAnn Int Med200313989390010.7326/0003-4819-139-11-200312020-00007
  • LowNEpidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infectionHealth Technol Assess2007118118610.3310/hta11080
  • MantJSystematic review and modelling of the investigation of acute and chronic chest pain presenting in primary careHealth Technol Assess200482117010.3310/hta8020
  • O’MearaJJA decision analysis of streptokinase plus heparin as compared to heparin alone for deep vein thrombosisN Engl J Med19943301864186910.1056/NEJM199406303302605
  • Office for National Statistics (2006). Interim life tables, United Kingdom 2003–2005. London: Office for National Statistics.
  • PrandoniPLensingAWACogoACuppiniSThe long-term clinical course of acute deep venous thrombosisAnn Intern Med19961251710.7326/0003-4819-125-1-199607010-00001
  • PrandoniPVillaltaSBagatellaPRossiLThe clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patientsHaematologica199782423428
  • PrinsMHHuttonBAKoopmanMMWBullerHRLong-term treatment of venous thromboembolic diseaseThromb Haemostasis199982892898
  • RoderickPThe cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: A discrete-event simulation modelHealth Technol Assess200376118610.3310/hta7060
  • SandercockPA systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHSHealth Technol Assess2002626111210.3310/hta6260
  • SimpsonELStevensonMDRawdinAPapaioannouDThrombophilia testing in people with venous thromboembolism: Systematic review and cost-effectiveness analysisHealth Technol Assess2009132111410.3310/hta13020
  • SteinKScreening for hepatitis C among injecting drug users and in genitourinary medicine clinics: Systematic reviews of effectiveness, modelling study and national survey of current practiceHealth Technol Assess20026311122
  • StinnettAMullahyJNet health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysesMed Decis Making199818S68S8010.1177/0272989X98018002S09
  • WeinsteinMCStatsonWBFoundations of cost effectiveness analysis for health and medical practicesN Eng J Med197729671610.1056/NEJM197703312961304
  • WillisBHCervical screening programmes: Can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UKHealth Technol Assess2005913122210.3310/hta9130
  • WoodroffeRClinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: A systematic review and modelling studyHealth Technol Assess2005921119410.3310/hta9210
  • WoolacottNEtanercept and infliximab for the treatment of psoriatic arthritis: A systematic review and economic evaluationHealth Technol Assess20061031125210.3310/hta10310
  • WuORobertsonLTwaddleSLoweGDOScreening for thrombophilia in high-risk situations: Systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS)Health Technol Assess200510111110

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.